Researchers have shown that they can measure those effects of the Corona pandemic on mental health by analyzing the language that people use to express their anxiety online.
Researchers have created artificial intelligence algorithm that can automatically identify patients at high risk of intentional self-harm, based on the information in the clinical notes in the electronic health record.
Digital phenotyping and machine learning have emerged as promising tools for monitoring patients with psychosis spectrum illnesses.
For the first time doctors have shown that measuring changes in 24-hour heart rate can reliably indicate whether or not someone is depressed.
Researchers have developed an innovative training protocol that, utilizing immersive virtual reality (IVR), leads to real physical and cognitive benefits.
A new randomized control trial has found that turning mobile mental health intervention into a smartphone game can potentially improve well-being.
Using VR to make threats appear near or far is what makes it harder to extinguish the fear of a close-up threat and more likely that you’ll have some long-term stress from the experience.
Akili announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRxTM (AKL-T01) as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD).
Researchers show chatbots could play a key role in helping people with issues around their health and wellbeing.
A new app that helps patients in self-isolation monitor for symptoms of COVID-19 and identify their mental health needs has been developed.
A new statistical technique from the field of machine learning is now making it possible to predict the success of smartphone-based interventions more accurately.
NanoEDGE research project aims at converging production techniques for functionalized electrodes with expertise in nanomaterial fabrication and characterization.